Dow and collaborators demonstrated that APC restoration in colon cancer cells could revert the malignant phenotype to functional differentiated intestinal units, thus inducing regression in tumors harboring KRASG12D and TRP53 mutations31. Here, TP53 is linked to malignant colon neoplasm.